December 2025 in “Journal of lasers in medical sciences” This randomized controlled trial reported that light-emitting diode therapy significantly reduced ecchymosis and edema and accelerated wound healing in patients during the first two weeks following rhinoplasty, without any adverse effects.
November 2025 in “The Bioscan.” This case report describes a 30-year-old man with alopecia areata who experienced recovery following treatment with the homeopathic medication Pix Liquida.
November 2025 in “Journal of English Language and Education” In this study, researchers found that a hair tonic formulated with 2% guava leaf extract demonstrated strong consumer acceptance and safe physicochemical characteristics among university students, showing potential as a natural alternative for reducing hair loss.
November 2025 in “BMC Endocrine Disorders” This study found that in PCOS patients, a lower TT/DHT ratio is associated with regular menstruation, while higher ratios are linked to insulin resistance, suggesting its potential as a biomarker for metabolic severity in these patients.
November 2025 in “Fayoum University Medical Journal/Fayoum University Medical Journal ” This study found that intralesional vitamin D3 injections significantly increased serum vitamin D3 levels in patients with localized alopecia areata, although baseline vitamin D3 levels did not predict disease severity or treatment response.
This study found that serum irisin levels were significantly lower in patients with androgenetic alopecia compared to healthy controls, but no significant relationship was detected between serum irisin levels and insulin resistance markers like BMI, fasting insulin, or HOMA-IR.
October 2025 in “Archives of Dermatological Research” Topical metformin gel is as effective and safe as steroids for treating alopecia areata.
October 2025 in “SAR Journal of Medical Biochemistry” In this research, the methanolic extract of Moringa oleifera seeds demonstrated potential antihelminthic activity in Indian adult earthworms, potentially offering fewer side effects compared to standard anthelmintic drugs like albendazole.
October 2025 in “Clinical Cosmetic and Investigational Dermatology” This study found that hair treated with a supplemental hair care product showed significantly higher absorption, deeper penetration, and reduced dryness compared to untreated and water-treated hair, as measured with 3D Raman spectroscopy.
September 2025 in “Journal of Cosmetic Dermatology” Single-needle radiofrequency is effective and safe for treating facial sebaceous hyperplasia.
August 2025 in “International Journal of Research in Ayurveda and Pharmacy” In this study, significant relief from symptoms of Darunaka, such as itching and dryness, was observed in a 14-year-old patient following treatment with an Ayurvedic formulation made from mango seed and Terminalia chebula powders.
August 2025 in “Dermatology and Therapy” This review reports that three JAK inhibitors—baricitinib, ritlecitinib, and deuruxolitinib—have gained FDA approval for treating alopecia areata due to their demonstrated efficacy in fostering hair regrowth in clinical trials.
August 2025 in “JOURNAL OF EXPERIMENTAL ZOOLOGY INDIA” This study reported that a spray containing Origanum marjoram essential oil significantly improved hair regrowth, dermal thickness, weight, and lymphocyte levels in rabbits with cyclophosphamide-induced alopecia, suggesting its potential as a natural alternative for hair loss treatment.
August 2025 in “Galen Medical Journal” In this study, among 2,000 patients with alopecia universalis, mesotherapy combined with systemic treatments like BMI, JAK inhibitors, and adalimumab showed the highest success in hair regrowth, particularly for children, with the combination therapy group achieving a 42% positive response rate.
July 2025 in “Russian Journal of Skin and Venereal Diseases” In this article, two patients with mild to moderate androgenetic alopecia showed improved hair density and reduced vellus hairs after treatment with exosome-derived solutions from salmon tissues, suggesting potential benefits of this approach.
July 2025 in “Biotechnology and Bioprocess Engineering” Spirulina extract may effectively promote hair growth and reduce inflammation, offering a natural alternative for hair loss treatment.
July 2025 in “Arab Board Medical Journal” This study found that patients with androgenetic alopecia had significantly higher serum NF-κB levels compared to controls, and these levels correlated with disease severity, suggesting NF-κB as a potential biomarker and therapeutic target.
July 2025 in “The Egyptian Journal of Hospital Medicine” This study found that serum GPER-1 levels may serve as a biomarker for differentiating androgenetic alopecia from telogen effluvium and healthy controls, although its ability to distinguish between AGA and TE is limited.
July 2025 in “ALEXMED ePosters” In this study, the researchers aimed to evaluate the levels of substance P, folic acid, and ferritin in the serum of female patients experiencing hair fall and trichodynia.
June 2025 in “Medical alphabet” The authors concluded that combining fractional lasers with topical therapy may be a promising and effective approach for treating androgenetic alopecia, offering high safety and tolerability.
June 2025 in “DiRROS repository (University of Maribor)” This study aimed to identify the factors that influence the clinical severity of scalp seborrheic dermatitis, although specific results are not reported.
May 2025 in “Archives of Dermatological Research” Patient-reported hair improvements align with actual hair density changes, not hair width.
This study evaluated the effect of intralesional injections of lyophilized Platelet Derived Growth Factors in 42 patients with Peyronie's disease and found significant reductions in penile curvature and plaque size, along with improvements in Peyronie's Disease Questionnaire scores, suggesting a potential treatment role.
May 2025 in “Russian Journal of Allergy” This study reported that combining fexofenadine or ebastine with topical therapy significantly improved hair regrowth and reduced the severity of alopecia areata over 12 weeks compared to topical treatment alone.
May 2025 in “AlQalam Journal of Medical and Applied Sciences” In this study, researchers found that while low serum ferritin levels are common among women, there was no clear association between those low levels and diffuse hair loss in patients with female pattern hair loss and chronic telogen effluvium.
April 2025 in “Düzce Tıp Fakültesi Dergisi” In this study, researchers examined vitamin D levels and blood count parameters in children and adolescents with non-scarring alopecia, finding significant vitamin D deficiency but no significant differences in deficiency or insufficiency across different types of alopecia.
The researchers observed that in cases of alopecia areata with atypical features, histopathological confirmation may be necessary, as trichoscopic clues like loss of follicle ostia and vellus hairs were common, while typical features such as exclamation mark hairs were not always present.
April 2025 in “Pharmaceutics” This study examined three olive oil formulations of baricitinib for topical delivery in treating alopecia areata, finding that Oil A showed the highest skin retention and maintained skin integrity without irritation, suggesting its potential for further investigation.
April 2025 in “Journal of Cosmetic and Laser Therapy” This study found that QR678 Neo® significantly enhanced hair regrowth, density, and shaft diameter in males with advanced androgenetic alopecia undergoing hair transplant surgery, compared to a conventional method, making it a promising adjunct treatment option.
April 2025 in “ALEXMED ePosters” This study found that nanofat injections significantly improved scar characteristics, including collagen deposition, epidermal thickness, and vascularity, due to its anti-inflammatory and immunomodulatory properties.